The stigma of depression left Deborah Gray suffering for 20 years with MDD before she was diagnosed.
Prior to penicillin, life expectancy was limited for patients with X-linked agammaglobulinemia. Thanks to the advent of intravenous immune globulin, the prognosis today is much more promising.
The Johnsons look like a picture-perfect family, but behind the smiles, this family faces the daily challenges, heartbreak and loss that come with a diagnosis of primary immunodeficiency
In this plasma-themed issue of BioSupplyTrends Quarterly, we take a critical look at each of these segments of the plasma market.
Kedrion President and CEO Paolo Marcucci discusses Kedrion's goal to strengthen its role as strategic partner of national health systems.
In this issue, we explore novel technologies shaping the future of the healthcare landscape.
David T. Rubin MD, assistant professor of medicine at the University of Chicago Pritzker School of Medicine, is a leading authority on Crohn’s disease and ulcerative colitis.
Tom Robinson refused to passively accept his diagnosis of debilitating Crohn’s disease and instead embarked on a journey that not only restored his health but launched a new career.
Results from a routine physical permanently altered the course of Jacques Whitfield’s life by revealing he was HIV positive. But for this patient-turned-advocate, promoting prevention has become his life’s passion.
As we celebrate our third year in publication, we begin by exploring innovations in vaccine research and technology.
Brent MacGregor, president of Novartis Vaccines, U.S., plans to build upon the current Novartis Vaccines culture, which he says promotes an entrepreneurial spirit coupled with an element of risk-taking that he thrives on.
Improved medications and lowered mortality rates have tasked providers with helping patients not only adhere to treatment plans, but also navigate the emotional and social implications of living long term with HIV.